Copyright
©The Author(s) 2020.
World J Gastrointest Oncol. Sep 15, 2020; 12(9): 1065-1072
Published online Sep 15, 2020. doi: 10.4251/wjgo.v12.i9.1065
Published online Sep 15, 2020. doi: 10.4251/wjgo.v12.i9.1065
Figure 4 Abdominal enhanced computed tomography images showing that liver lesions changed during lapatinib therapy.
A: Jun 29, 2018: Before lapatinib therapy; B: Sep 20, 2018: 2 mo of lapatinib therapy; C: Mar 11, 2019: Disease progression after lapatinib treatment for 7.9 mo.
- Citation: Guan JL, Liu JH, Wang Q, Cong YW, Chen YX, Huang KF, Huang ML, Huang L. Response of human epidermal growth factor receptor 2-positive colorectal cancer to lapatinib monotherapy: A case report. World J Gastrointest Oncol 2020; 12(9): 1065-1072
- URL: https://www.wjgnet.com/1948-5204/full/v12/i9/1065.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v12.i9.1065